4//SEC Filing
Loose Christopher R. 4
Accession 0000950170-23-035163
CIK 0001703647other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:16 PM ET
Size
7.0 KB
Accession
0000950170-23-035163
Insider Transaction Report
Form 4
Loose Christopher R.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-07-26$0.51/sh−1,329$678→ 186,367 total - Sale
Common Stock
2023-07-25$0.50/sh−1,390$695→ 187,696 total
Footnotes (3)
- [F1]Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.491 to $0.513. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.511 to $0.515. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Documents
Issuer
Frequency Therapeutics, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001785299
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 4:16 PM ET
- Size
- 7.0 KB